Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomihisa Niitsu

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Journal of Psychiatric Research|May 19, 2026
A retrospective comparative analysis of the clinical response to clozapine between patients with early and late treatment-resistant schizophreniaKazuki Okada, Nobuhisa Kanahara, Yuji Otsuka, et al.
Plos One|August 19, 2016
Increased Serum Levels of Oxytocin in 'Treatment Resistant Depression in Adolescents (TRDIA)' GroupTsuyoshi Sasaki, Kenji Hashimoto, Yasunori Oda, et al.
Asian Journal of Psychiatry|July 3, 2021
Risk factors for early-phase clozapine discontinuation: A nested case-control studyMariko Tsukiji, Tsuyoshi Sasaki, Yusuke Nakata, et al.
Psychotherapy and Psychosomatics|May 28, 2016
Cognitive Behavioral Therapy for Patients with Social Anxiety Disorder Who Remain Symptomatic following Antidepressant Treatment: A Randomized, Assessor-Blinded, Controlled TrialNaoki Yoshinaga, Satoshi Matsuki, Tomihisa Niitsu, et al.
Frontiers in Psychiatry|March 13, 2024
Association of <i>SLC6A3</i> variants with treatment-resistant schizophrenia: a genetic association study of dopamine-related genes in schizophreniaMasanobu Kogure, Nobuhisa Kanahara, Atsuhiro Miyazawa, et al.
Psychiatry Research|May 14, 2021
Serum levels of glial cell line-derived neurotrophic factor as a biomarker for mood disorders and lithium responseKeita Idemoto, Tomihisa Niitsu, Tatsuki Hata, et al.
Journal of Psychiatric Research|December 28, 2020
Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorderKeita Idemoto, Tamaki Ishima, Tomihisa Niitsu, et al.
Asian Journal of Psychiatry|September 13, 2020
A randomized-controlled trial of blonanserin and olanzapine as adjunct to antipsychotics in the treatment of patients with schizophrenia and dopamine supersensitivity psychosis: The ROADS studyTomihisa Niitsu, Tatsuki Hata, Masahiko Nishimoto, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Journal of Psychiatric Research|May 19, 2026
A retrospective comparative analysis of the clinical response to clozapine between patients with early and late treatment-resistant schizophreniaKazuki Okada, Nobuhisa Kanahara, Yuji Otsuka, et al.
Plos One|August 19, 2016
Increased Serum Levels of Oxytocin in 'Treatment Resistant Depression in Adolescents (TRDIA)' GroupTsuyoshi Sasaki, Kenji Hashimoto, Yasunori Oda, et al.
Asian Journal of Psychiatry|July 3, 2021
Risk factors for early-phase clozapine discontinuation: A nested case-control studyMariko Tsukiji, Tsuyoshi Sasaki, Yusuke Nakata, et al.
Psychotherapy and Psychosomatics|May 28, 2016
Cognitive Behavioral Therapy for Patients with Social Anxiety Disorder Who Remain Symptomatic following Antidepressant Treatment: A Randomized, Assessor-Blinded, Controlled TrialNaoki Yoshinaga, Satoshi Matsuki, Tomihisa Niitsu, et al.
Frontiers in Psychiatry|March 13, 2024
Association of <i>SLC6A3</i> variants with treatment-resistant schizophrenia: a genetic association study of dopamine-related genes in schizophreniaMasanobu Kogure, Nobuhisa Kanahara, Atsuhiro Miyazawa, et al.
Psychiatry Research|May 14, 2021
Serum levels of glial cell line-derived neurotrophic factor as a biomarker for mood disorders and lithium responseKeita Idemoto, Tomihisa Niitsu, Tatsuki Hata, et al.
Journal of Psychiatric Research|December 28, 2020
Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorderKeita Idemoto, Tamaki Ishima, Tomihisa Niitsu, et al.
Asian Journal of Psychiatry|September 13, 2020
A randomized-controlled trial of blonanserin and olanzapine as adjunct to antipsychotics in the treatment of patients with schizophrenia and dopamine supersensitivity psychosis: The ROADS studyTomihisa Niitsu, Tatsuki Hata, Masahiko Nishimoto, et al.
Pageof 7